PL316040A1 - Pharmaceutic compositions - Google Patents

Pharmaceutic compositions

Info

Publication number
PL316040A1
PL316040A1 PL95316040A PL31604095A PL316040A1 PL 316040 A1 PL316040 A1 PL 316040A1 PL 95316040 A PL95316040 A PL 95316040A PL 31604095 A PL31604095 A PL 31604095A PL 316040 A1 PL316040 A1 PL 316040A1
Authority
PL
Poland
Prior art keywords
pharmaceutic compositions
pharmaceutic
compositions
Prior art date
Application number
PL95316040A
Inventor
Meena Aggarwal
John Neville Hague
Karrar Ahmad Khan
Alan Smith
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of PL316040A1 publication Critical patent/PL316040A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
PL95316040A 1994-03-05 1995-03-02 Pharmaceutic compositions PL316040A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9404248A GB9404248D0 (en) 1994-03-05 1994-03-05 Pharmaceutical formulations
PCT/EP1995/000791 WO1995023596A1 (en) 1994-03-05 1995-03-02 Adhesive free topical pharmaceutical formulations

Publications (1)

Publication Number Publication Date
PL316040A1 true PL316040A1 (en) 1996-12-23

Family

ID=10751332

Family Applications (1)

Application Number Title Priority Date Filing Date
PL95316040A PL316040A1 (en) 1994-03-05 1995-03-02 Pharmaceutic compositions

Country Status (10)

Country Link
EP (1) EP0749301A1 (en)
JP (1) JPH09509675A (en)
AU (1) AU691583B2 (en)
CZ (1) CZ258596A3 (en)
GB (1) GB9404248D0 (en)
NZ (1) NZ281633A (en)
PL (1) PL316040A1 (en)
SK (1) SK113296A3 (en)
WO (1) WO1995023596A1 (en)
ZA (1) ZA951781B (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0858805A3 (en) * 1997-02-13 1998-09-02 National Research Institute of Chinese Medicine Transdermal preparations of oxicams
US7017573B1 (en) 1999-07-12 2006-03-28 Capnia, Incorporated Methods and apparatus for relieving headaches, rhinitis and other common ailments
US20060172017A1 (en) 1999-11-08 2006-08-03 Capnia, Incorporated Methods and apparatus for the enhanced delivery of physiologic agents to tissue surfaces
US20070039615A1 (en) 1999-11-08 2007-02-22 Capnia, Incorporated Methods and apparatus for treating rhinitis
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
WO2004060347A2 (en) * 2002-09-03 2004-07-22 Transform Pharmaceuticals, Inc. Pharmaceutical propylene glycol solvate compositions
US7927613B2 (en) 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
AU2003213719A1 (en) 2002-03-01 2003-09-16 Regents Of The University Of Michigan Multiple-component solid phases containing at least one active pharmaceutical ingredient
EP1515703A1 (en) * 2002-06-21 2005-03-23 Transform Pharmaceuticals, Inc. Pharmaceutical compositions with improved dissolution
GB0518769D0 (en) * 2005-09-14 2005-10-19 Medpharm Ltd Topical formulations
HU227970B1 (en) 2007-07-10 2012-07-30 Egis Gyogyszergyar Nyrt Pharmaceutical compositions containing silicones of high volatility
BRPI0921685A2 (en) * 2008-10-31 2016-02-16 Moberg Derma Ab a topical composition comprising a combination of at least two penetration enhancing agents.
TR200907179A1 (en) 2009-09-18 2011-04-21 Sanovel İlaç San. Ve Ti̇c. A. Ş. Flurbiprofen and muscle relaxant combinations
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
EP2468270A1 (en) * 2010-12-21 2012-06-27 GALENpharma GmbH (R)-2-(3-fluoro-4-phenylphenyl)propionic acid for use in the treatment of skin diseases
DK2704703T3 (en) 2011-05-03 2019-10-14 Aponia Laboratories Inc TRANSDERMAL COMPOSITIONS OF THE IBUPROFEN AND PROCEDURES FOR USING IT
US20140377343A1 (en) 2011-12-23 2014-12-25 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Formulations of flurbiprofen and diacerein
US20140371318A1 (en) 2011-12-23 2014-12-18 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Orally-disintegrating formulations of flurbiprofen
WO2013095320A1 (en) 2011-12-23 2013-06-27 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Flurbiprofen formulations
US10045935B2 (en) 2012-07-31 2018-08-14 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
US11154535B2 (en) 2012-07-31 2021-10-26 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
US10596117B1 (en) 2014-12-31 2020-03-24 Eric Morrison Lipoleosomes as carriers for aromatic amide anesthetic compounds
US10561627B2 (en) 2014-12-31 2020-02-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermetic surfactant films
US11007161B1 (en) 2014-12-31 2021-05-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermatic surfactant films
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
EP3452023A1 (en) 2016-05-05 2019-03-13 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine compositions
CA3085488A1 (en) * 2017-12-11 2019-06-20 Meat & Livestock Australia Ltd Transdermal analgesic formulation
ES2835399B2 (en) * 2019-12-20 2022-03-23 Univ Jaen Procedure for obtaining a textile material carrying molecules of pharmacological interest and material thus obtained

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB119646A (en) * 1917-10-05 1919-07-04 Hendrik Johannes Chr Hengeveld Wadding for Curing Rheumatism.
GB1191646A (en) * 1966-10-05 1970-05-13 American Gage & Mach Recording Apparatus
GB2075837B (en) * 1980-05-14 1984-03-14 Hisamitsu Pharmaceutical Co Topical pharmaceutical gel containing anti-inflammatory analgesic agents
JPS57140711A (en) * 1981-02-26 1982-08-31 Teika Seiyaku Kk Poultice for anti-inflammatory and analgesic use and its preparation
JPH0662401B2 (en) * 1985-04-25 1994-08-17 久光製薬株式会社 Ketoprofen-containing patch
DE3522550A1 (en) * 1985-06-24 1987-01-02 Klinge Co Chem Pharm Fab SPRAYABLE PHARMACEUTICAL PREPARATION FOR TOPICAL APPLICATION
JPS6399866A (en) * 1986-10-17 1988-05-02 石田　賢司 Lint cloth having drug coated surface and its production
JP2570342B2 (en) * 1987-12-01 1997-01-08 日産化学工業株式会社 External solution
CA1331137C (en) * 1988-02-29 1994-08-02 Pfizer, Inc. Transdermal flux enhancing compositions
US5061724A (en) * 1989-07-18 1991-10-29 Sheldon Gertner Method for treating arthritically inflamed body joints, particularly joints having gouty arthritis
US5093133A (en) * 1990-01-24 1992-03-03 Mcneil-Ppc, Inc. Method for percutaneous delivery of ibuprofen using hydroalcoholic gel
WO1992005768A1 (en) * 1990-10-05 1992-04-16 Analgesic Associates Prevention or treatment of sunburn using the s(+) isomer of flurbiprofen
JPH1143831A (en) * 1997-07-22 1999-02-16 Murata Mach Ltd Spinning device

Also Published As

Publication number Publication date
AU691583B2 (en) 1998-05-21
EP0749301A1 (en) 1996-12-27
AU1850295A (en) 1995-09-18
GB9404248D0 (en) 1994-04-20
CZ258596A3 (en) 1996-12-11
SK113296A3 (en) 1997-05-07
ZA951781B (en) 1995-09-05
NZ281633A (en) 1998-04-27
WO1995023596A1 (en) 1995-09-08
JPH09509675A (en) 1997-09-30

Similar Documents

Publication Publication Date Title
PL316040A1 (en) Pharmaceutic compositions
ZA957233B (en) Topically-effective compositions
EG20929A (en) Cleasing compositions
GB9408545D0 (en) Compositions
PL336980A1 (en) Pharmaceutic composition
PL330223A1 (en) Pharmaceutic composition
HU9503199D0 (en) Pharmaceutical basic compositions
PL324341A1 (en) Pharmaceutic compositions and compounds
EP0755250A4 (en) Benzamide-containing pharmaceutical compositions
PL334006A1 (en) Lyophilisable pharmaceutic compositions
PL329919A1 (en) Diclophenac-based pharmaceutic compositions
PL336038A1 (en) Pharmaceutic compositions
GB9409543D0 (en) Compositions
PL319511A1 (en) Parenteral pharmaceutic compositions containing gf120918a
GB9502770D0 (en) Amine-curable compositions
GB9411292D0 (en) Pharmaceuticals compositions
ZA954709B (en) Mineral-fiber compositions
GB2290299B (en) Anti-lubricant compositions
GB9406835D0 (en) Pharmaceutical compositions
GB9416768D0 (en) Compositions
EP0705632A3 (en) 2-Methylpropenyl-terminated polyisobutylene-polydimethyl-siloxane compositions
GB2295825B (en) Pharmaceutical compositions
GB9400047D0 (en) Pharmaceutical compositions
PL335729A1 (en) Pharmaceutic compositions
GB9416767D0 (en) Compositions